Saving changes...

Done

Error

Challenges in HIV Prevention:A Case Study

Challenges in HIV Prevention:A Case Study

Challenges in HIV Prevention:A Case Study

Omar Daoud, PharmD
Omar Daoud, PharmD
on behalf of Postgraduate Healthcare Education, LLC

FREE
FREE
FREE

FREE
FREE
FREE

null FREE
FREE
FREE
null FREE
FREE
FREE
Normal Price: FREE FREE

Review:

Launch date: 13 Mar 2017
Expiry Date:

Last updated: 15 Mar 2017

Reference: 172096

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

According to the Centers for Disease Control and Prevention, the number of new HIV diagnoses fell 19% from 2005 to 2014, yet nearly 40 000 people were diagnosed with HIV infection in the United States in 2015. Gay and bisexual men accounted for 82% of male patients diagnosed with HIV and 67% of diagnoses overall. Several clinical trials have demonstrated both safety and a substantial reduction in the rate of HIV acquisition in men who have sex with men (MSM), men and women that make up an HIV-discordant couple, and heterosexual men and women, with a specific regimen of antiretroviral therapy (ART), which is now Food and Drug Administration-approved as pre-exposure prophylaxis (PrEP) for HIV. As with ART for HIV treatment, PrEP requires high levels of adherence to achieve efficacy, and poor adherence increases the risk of other consequences. For those exposed to HIV without PrEP, a post-exposure prophylaxis (PEP) regimen has also shown high efficacy with good adherence, and initiation within 72 hours of exposure. This activity will review the recommended strategies for HIV prevention (PrEP and PEP) with a focus on MSM.

Objectives

Objectives
At the conclusion of this activity, the participant should be able to:

-Assess whether a patient is a good candidate for PrEP or PEP.
-Evaluate proper protocol for HIV testing and management based on risk of HIV exposure.
-Recommend strategies to cope with social challenges and increase patient adherence with HIV prevention therapy.
Omar Daoud, PharmD

Author Information Play Video Bio

Omar Daoud, PharmD
on behalf of Postgraduate Healthcare Education, LLC

Omar Daoud, PharmD (Chair/Author) Walgreens Pharmacy Seattle, Washington

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 0.50 Hours -
    Reference: 0064-0000-16-232-H02-P

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error